Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Search for Market Research Reports:    

Cardiovascular Outlook: Pharmaceutical, Medical Device, New Technologies - Past, Present, and Future

Published by: PharmaLive Special Reports

Published: Oct. 1, 2009 - 171 Pages


Table of Contents


The following information is included in this special report, which reviews the leading disease/medical-use areas within the cardiovascular therapeutic category.




Primary cardiovascular areas covered:

1. Hypertension

2. Cholesterol

3. Thrombosis, broken down by venous thromboembolism and atherothrombosis

4. Coronary artery disease and atherosclerosis, including a focus on medical-device stents

5. Pulmonary arterial hypertension


For these five areas, various charts and analysis of the current market leaders and anticipated future growth drivers are provided.



Prescription-drug pipeline covering various cardiovascular indications, detailing the following for each product:

  • Each pipeline products’ chemical or substance composition, intended indication, class of drug, clinical status, region of development, and the product developer/intended marketer


  • Pipeline status details preclinical development, Phase I, Phase II, Phase II/III, Phase III, and awaiting approval

  • Region of development includes the United States, Europe, and Japan


Directory of about 175 cardiovascular prescription-drug developers and marketers, encompassing this information for each company:
  • Mailing address

  • General phone, fax, e-mail, and Website

  • Year established


Listing of about 2,000 cardiovascular medical-device entries, sorted by device class, with the following details for each product:
  • Product code

  • Product description

  • Registration number

  • Company


Directory of about 1,000 medical-device company entries (includes divisions and subsidiaries) that are associated with cardio devices, with the following information for each company:
  • FDA Establishment Registration Number

  • Mailing address

  • General phone, fax, e-mail, and Website

  • Year established

Abstract

Cardiovascular disease is the leading cause of death in the United States, affecting an estimated 80.7 million American adults, with estimated treatment costs of more than $313.8 billion annually. This report contains qualitative analysis of market-leading brands in five primary cardiovascular segments with statistical data and analytical reviews of revenue and investment activity by brand and device. Readers will get an understanding of future growth drivers that will affect specific disease classes within this therapeutic category, and will have the ability to track potential competitive products, learn how these could affect your company's bottom-line, and gain insight into the revenue implications of brands coming off patent and generic competition.

Get Full Details About This Report >>
US: 800.298.5699
Int'l: +1.240.747.3093
Buy this Report

Price and Delivery Options
See related reports or call the number above for help from a research specialist.


 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 300,000 market research reports, company profiles and country profiles from over 700 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

 

© MarketResearch.com 2012
2/14/2012 - 30